Amgen soars 14% on positive weight-loss drug data



Shares of Amgen Inc. rallied during Friday’s premarket hours after the biotech giant shared upbeat opening-quarter results for fiscal 2024. The company booked $7.4 billion in revenue, surging by 22% c…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento